Weston L. Daniel

6.2k total citations · 2 hit papers
27 papers, 5.2k citations indexed

About

Weston L. Daniel is a scholar working on Molecular Biology, Electronic, Optical and Magnetic Materials and Biomedical Engineering. According to data from OpenAlex, Weston L. Daniel has authored 27 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 7 papers in Electronic, Optical and Magnetic Materials and 6 papers in Biomedical Engineering. Recurrent topics in Weston L. Daniel's work include Advanced biosensing and bioanalysis techniques (17 papers), RNA Interference and Gene Delivery (9 papers) and Gold and Silver Nanoparticles Synthesis and Applications (7 papers). Weston L. Daniel is often cited by papers focused on Advanced biosensing and bioanalysis techniques (17 papers), RNA Interference and Gene Delivery (9 papers) and Gold and Silver Nanoparticles Synthesis and Applications (7 papers). Weston L. Daniel collaborates with scholars based in United States, Canada and Hong Kong. Weston L. Daniel's co-authors include Chad A. Mirkin, David A. Giljohann, Pinal C. Patel, Dwight S. Seferos, Matthew D. Massich, Andrew E. Prigodich, Stephen J. Lippard, Shanta Dhar, Min Su Han and Jae‐Seung Lee and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Journal of Clinical Oncology.

In The Last Decade

Weston L. Daniel

27 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gold Nanoparticles for Biology and Medicine

2010 2.0k citations David A. Giljohann, Dwight S. Seferos et al. Angewandte Chemie International Edition profile →
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma

2013 493 citations Samuel A. Jensen, Emily S. Day et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weston L. Daniel United States	19	3.1k	1.7k	1.7k	1.3k	999	27	5.2k
Pinal C. Patel United States	16	3.5k 1.1×	1.6k 0.9×	1.6k 1.0×	1.5k 1.2×	1.1k 1.1×	18	5.4k
Gary B. Braun United States	42	2.5k 0.8×	2.2k 1.3×	1.7k 1.0×	1.6k 1.2×	835 0.8×	69	5.3k
Rochelle R. Arvizo United States	18	1.5k 0.5×	1.3k 0.8×	1.4k 0.8×	712 0.5×	1.3k 1.3×	21	3.7k
Dingbin Liu China	44	4.0k 1.3×	3.8k 2.2×	2.5k 1.5×	1.7k 1.3×	1.0k 1.0×	130	7.5k
Cheng Cui China	42	4.6k 1.5×	2.2k 1.3×	1.4k 0.8×	374 0.3×	776 0.8×	119	6.7k
Jaemoon Yang South Korea	40	1.8k 0.6×	2.7k 1.6×	1.6k 1.0×	850 0.6×	1.9k 1.9×	155	6.3k
Shuaidong Huo China	32	2.0k 0.6×	2.8k 1.6×	2.2k 1.3×	768 0.6×	2.0k 2.0×	69	5.7k
Xinglu Huang China	41	2.2k 0.7×	3.0k 1.7×	2.8k 1.7×	511 0.4×	2.2k 2.2×	84	6.5k
Zilong Zhao China	41	4.4k 1.4×	3.2k 1.9×	1.9k 1.2×	318 0.2×	1.1k 1.1×	98	6.9k
Seungjoo Haam South Korea	42	1.8k 0.6×	3.5k 2.0×	2.3k 1.4×	966 0.7×	2.7k 2.7×	144	6.8k

Countries citing papers authored by Weston L. Daniel

Since Specialization

Citations

This map shows the geographic impact of Weston L. Daniel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weston L. Daniel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weston L. Daniel more than expected).

Fields of papers citing papers by Weston L. Daniel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weston L. Daniel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weston L. Daniel. The network helps show where Weston L. Daniel may publish in the future.

Co-authorship network of co-authors of Weston L. Daniel

This figure shows the co-authorship network connecting the top 25 collaborators of Weston L. Daniel. A scholar is included among the top collaborators of Weston L. Daniel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weston L. Daniel. Weston L. Daniel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Schroff, Matthias, et al.. (2023). Cavrotolimod, a Nanoparticle Toll-like Receptor 9 Agonist, Inhibits Tumor Growth and Alters Immune Cell Composition in Mouse Models of Skin Cancer. ACS Applied Nano Materials. 6(4). 2682–2696. 1 indexed citations

2.

Daniel, Weston L., et al.. (2022). A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation. Frontiers in Immunology. 13. 1073777–1073777. 20 indexed citations

3.

Milhem, Mohammed, Cesar A. Perez, Glenn J. Hanna, et al.. (2020). AST-008: A novel approach to TLR9 agonism with PD-1 blockade for anti-PD-1 refractory Merkel cell carcinoma (MCC) and cutaneous squamous cell carcinoma (CSCC).. Journal of Clinical Oncology. 38(15_suppl). TPS3164–TPS3164. 5 indexed citations

4.

Liu, Haoming, Richard S. Kang, Jeong Min Yu, et al.. (2019). Targeting the IL-17 Receptor Using Liposomal Spherical Nucleic Acids as Topical Therapy for Psoriasis. Journal of Investigative Dermatology. 140(2). 435–444.e4. 49 indexed citations

5.

Daniel, Weston L., et al.. (2019). Abstract CT044: AST-008, a TLR9 agonist spherical nucleic acid, activated NK cells, T cells, and cytokines in healthy subjects in a Phase I clinical trial. Cancer Research. 79(13_Supplement). CT044–CT044. 5 indexed citations

6.

Kouri, Fotini M., Lisa Hurley, Weston L. Daniel, et al.. (2015). miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes & Development. 29(7). 732–745. 179 indexed citations

7.

Jensen, Samuel A., Emily S. Day, Caroline H. Ko, et al.. (2013). Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma. Science Translational Medicine. 5(209). 209ra152–209ra152. 493 indexed citations breakdown →

8.

Prigodich, Andrew E., Pratik S. Randeria, William E. Briley, et al.. (2012). Multiplexed Nanoflares: mRNA Detection in Live Cells. Analytical Chemistry. 84(4). 2062–2066. 244 indexed citations

9.

Xu, Xiaoyang, Weston L. Daniel, Wei Wei, & Chad A. Mirkin. (2010). Colorimetric Cu²⁺ Detection Using DNA‐Modified Gold‐Nanoparticle Aggregates as Probes and Click Chemistry. Small. 6(5). 623–626. 235 indexed citations

10.

Patel, Pinal C., David A. Giljohann, Weston L. Daniel, et al.. (2010). Scavenger Receptors Mediate Cellular Uptake of Polyvalent Oligonucleotide-Functionalized Gold Nanoparticles. Bioconjugate Chemistry. 21(12). 2250–2256. 309 indexed citations

11.

Giljohann, David A., Dwight S. Seferos, Weston L. Daniel, et al.. (2010). Gold Nanoparticles for Biology and Medicine. Angewandte Chemie International Edition. 49(19). 3280–3294. 1973 indexed citations breakdown →

12.

Dhar, Shanta, Weston L. Daniel, David A. Giljohann, Chad A. Mirkin, & Stephen J. Lippard. (2010). Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads. Journal of the American Chemical Society. 132(8). 2845–2845. 5 indexed citations

13.

Dhar, Shanta, Weston L. Daniel, David A. Giljohann, Chad A. Mirkin, & Stephen J. Lippard. (2010). Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads. Journal of the American Chemical Society. 132(48). 17335–17335. 13 indexed citations

14.

Prigodich, Andrew E., One‐Sun Lee, Weston L. Daniel, et al.. (2010). Tailoring DNA Structure To Increase Target Hybridization Kinetics on Surfaces. Journal of the American Chemical Society. 132(45). 16296–16296. 4 indexed citations

15.

Zheng, Zijian, Weston L. Daniel, Louise R. Giam, et al.. (2009). Multiplexed Protein Arrays Enabled by Polymer Pen Lithography: Addressing the Inking Challenge. Angewandte Chemie International Edition. 48(41). 7626–7629. 102 indexed citations

16.

Kim, Young‐Pil, Weston L. Daniel, Zuyong Xia, et al.. (2009). Bioluminescent nanosensors for protease detection based upon gold nanoparticle–luciferase conjugates. Chemical Communications. 46(1). 76–78. 87 indexed citations

17.

Zheng, Zijian, Weston L. Daniel, Louise R. Giam, et al.. (2009). Multiplexed Protein Arrays Enabled by Polymer Pen Lithography: Addressing the Inking Challenge. Angewandte Chemie. 121(41). 7762–7765. 27 indexed citations

18.

Daniel, Weston L., Min Su Han, Jae‐Seung Lee, & Chad A. Mirkin. (2009). Colorimetric Nitrite and Nitrate Detection with Gold Nanoparticle Probes and Kinetic End Points. Journal of the American Chemical Society. 131(18). 6362–6363. 315 indexed citations

19.

Kim, Dong‐Woo, Weston L. Daniel, & Chad A. Mirkin. (2009). Microarray-Based Multiplexed Scanometric Immunoassay for Protein Cancer Markers Using Gold Nanoparticle Probes. Analytical Chemistry. 81(21). 9183–9187. 150 indexed citations

20.

Zheng, Gengfeng, Weston L. Daniel, & Chad A. Mirkin. (2008). A New Approach to Amplified Telomerase Detection with Polyvalent Oligonucleotide Nanoparticle Conjugates. Journal of the American Chemical Society. 130(30). 9644–9645. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact